Mark Alan Goldberg, Director at GLYCOMIMETICS INC (GLYC), bought 10,397 shares at $4.77 ($50K) on 2016-03-04, disclosed to the SEC on 2016-03-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| BPMC | SELL | 2020-12-22 | $654K | — | Filing → |
| BPMC | SELL | 2020-12-15 | $627K | — | Filing → |
| BPMC | SELL | 2020-12-03 | $600K | — | Filing → |